Page last updated: 2024-11-01

ondansetron and Hyperglycemia, Postprandial

ondansetron has been researched along with Hyperglycemia, Postprandial in 1 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Hyperglycemia, Postprandial: Abnormally high BLOOD GLUCOSE level after a meal.

Research Excerpts

ExcerptRelevanceReference
"Quipazine-treated, hyperglycemic animals did not show any increase in plasma insulin levels."1.33Hyperglycemia induced by pharmacological activation of central serotonergic pathways depends on the functional integrity of brain CRH system and 5-HT3 receptors. ( Barros, D; Carvalho, F; de Castro-E-Silva, E; Fregoneze, J; Rezende, E; Silva, J; Soares, M, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carvalho, F1
Barros, D1
Silva, J1
Rezende, E1
Soares, M1
Fregoneze, J1
de Castro-E-Silva, E1

Other Studies

1 other study available for ondansetron and Hyperglycemia, Postprandial

ArticleYear
Hyperglycemia induced by pharmacological activation of central serotonergic pathways depends on the functional integrity of brain CRH system and 5-HT3 receptors.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2005, Volume: 37, Issue:8

    Topics: Animals; Blood Glucose; Corticotropin-Releasing Hormone; Hyperglycemia; Indazoles; Insulin; Male; On

2005